13F Holdings
中文EN

HAO Haoxi Health Technology Ltd Annual reports only

Services-Advertising Agencies · Nasdaq · SEC CIK 1954594 · Fiscal year ends 06/30

Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY67.1%
TTM net income YoY-346.0%
TTM EPS YoY-111.4%
Revenue 3-yr CAGR24.8%
Net income 3-yr CAGR—

Margins

Gross margin1.1%
Operating margin-17.6%
Net margin-17.4%
FCF margin—
EBITDA margin-17.1%

Returns

ROE-54.1%
ROA-44.2%
ROIC (approx.)-93.7%
Asset turnover2.54x

Leverage & solvency

Liabilities / assets17.2%
Debt / equity0.00x
Current ratio4.53x
Interest coverage-184.27x

Cash quality & payout

Operating cash flow / net income0.27x
Accruals ratio-32.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$54.83M$32.80M$48.52M$28.23M$16.16M
Cost of revenue$54.20M$31.88M$45.77M$26.17M$15.51M
Gross profit$629,090$927,750$2.75M$2.06M$648,721
R&D expense$104,357$79,544$79,985$58,161$102,524
SG&A expense$8.61M$2.80M$911,531$775,961$239,941
Operating income-$9.66M-$2.00M$1.72M$1.20M$268,768
Interest expense$52,446$45,956$41,186$19,775—
Pretax income-$9.50M$4.15M$1.74M$1.19M$259,595
Income tax$36,614$270,744$443,582$220,653$15,008
Net income-$9.54M$3.88M$1.29M$969,752$244,587
EBITDA-$9.36M-$1.71M$1.73M$1.20M$270,980
EPS (basic)-386.404,251.812,701.530.870.01
EPS (diluted)-386.403,385.532,701.530.870.01
Weighted avg. shares (diluted)24,6809364781.10M25.00M
Balance sheet
Cash & equivalents$10.93M$8.62M$6.66M$1.20M$293,511
Receivables$5,944$460,272$226,747$7,748—
Current assets$16.81M$19.60M$15.38M$3.67M—
PP&E, net$104,169$108,899$126,743$143,836—
Intangibles—$1.80M———
Total assets$21.57M$21.60M$15.51M$4.46M—
Current liabilities$3.71M$3.91M$3.87M$2.58M—
Short-term debt$290,710$300,338$833,521$27,344—
Long-term debt—$307,323$301,678$249,107—
Total debt—$607,661$1.14M$276,451—
Total liabilities$3.71M$4.22M$4.23M$2.90M—
Shareholders' equity$17.86M$17.38M$11.27M$1.57M-$1.47M
Net debt—-$8.01M-$5.52M-$926,752—
Cash flow statement
Operating cash flow-$2.57M-$3.36M-$747,576-$872,132-$675,361
Capital expenditure——$55,367$45,500$8,698
Free cash flow——-$802,943-$917,632-$684,059
Investing cash flow-$4.50M-$3.58M-$3.13M-$45,500-$8,698
Financing cash flow$9.33M$8.90M$9.32M$1.80M$933,219
Depreciation & amortization$308,615$294,611$10,567$8,393$2,212
Stock-based compensation—$58,602———

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.